CFLT — Confluent Income Statement
0.000.00%
Last trade - 00:00- $7.73bn
- $6.89bn
- $963.64m
Annual income statement for Confluent, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 237 | 388 | 586 | 777 | 964 |
| Cost of Revenue | |||||
| Gross Profit | 161 | 251 | 384 | 547 | 706 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 470 | 727 | 1,049 | 1,256 | 1,383 |
| Operating Profit | -233 | -340 | -463 | -479 | -419 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -230 | -340 | -446 | -407 | -335 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -230 | -343 | -453 | -443 | -345 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -230 | -343 | -453 | -443 | -345 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -230 | -343 | -453 | -443 | -345 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.91 | -1.26 | -1.62 | -1.4 | -1.07 |
| Dividends per Share |